Monsels Solution
FDA Label NDC 10481-0112

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Gordon Laboratories for the product Monsels Solution (NDC 10481-0112). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding how supplied, indications & usage, warnings and precautions, other, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

How Supplied

Light-resistant 2 ml  bottles.

Indications & Usage

Used as a styptic in its undiluted form.

Warnings And Precautions

It should not be used in vesicular, bullous, or exudative (oozing) dermatoses because it may then cause permanent pigmentation on the  skin.  May be harmful  if swallowed. For  external use only.  If  swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention immediately. Keep out of reach of children. 

Other

Restricted to use by or on the order of a licensed Physician. Store at room temperature. Keep cap tightly sealed and protect from light.

Package Label.Principal Display Panel

Image Of Monsels Labels (Mns2oz)

Image Of Monsels Labels (Mns2oz)

* Please review the disclaimer below.